We have selected three bladder cancer cell lines (T24, 5637, and HT1376), representative of two distinct molecular pathways to invasive cancer (FGFR3/CCND1and E2F3/RB1), and widely explored by us in the establishment of novel therapeutic schemes. The gene discussed is E2F3; the disease is urinary bladder carcinoma.